Soto Antonio G, Trejo JoAnn
Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California 92093-0636, USA.
J Biol Chem. 2010 Jun 11;285(24):18781-93. doi: 10.1074/jbc.M110.111088. Epub 2010 Apr 5.
Protease-activated receptor-1 (PAR1) contains five N-linked glycosylation consensus sites as follows: three residing in the N terminus and two localized on the surface of the second extracellular loop (ECL2). To study the effect of N-linked glycosylation in the regulation of PAR1 signaling and trafficking, we generated mutants in which the critical asparagines of the consensus sites were mutated. Here, we report that both the PAR1 N terminus and ECL2 serve as sites for N-linked glycosylation but have different functions in the regulation of receptor signaling and trafficking. N-Linked glycosylation of the PAR1 N terminus is important for transport to the cell surface, whereas the PAR1 mutant lacking glycosylation at ECL2 (NA ECL2) trafficked to the cell surface like the wild-type receptor. However, activated PAR1 NA ECL2 mutant internalization was impaired compared with wild-type receptor, whereas constitutive internalization of unactivated receptor remained intact. Remarkably, thrombin-activated PAR1 NA ECL2 mutant displayed an enhanced maximal signaling response compared with wild-type receptor. The increased PAR1 NA ECL2 mutant signaling was not due to defects in the ability of thrombin to cleave the receptor or signal termination mechanisms. Rather, the PAR1 NA ECL2 mutant displayed a greater efficacy in thrombin-stimulated G protein signaling. Thus, N-linked glycosylation of the PAR1 extracellular surface likely influences ligand docking interactions and the stability of the active receptor conformation. Together, these studies strongly suggest that N-linked glycosylation of PAR1 at the N terminus versus the surface of ECL2 serves distinct functions critical for proper regulation of receptor trafficking and the fidelity of thrombin signaling.
蛋白酶激活受体-1(PAR1)含有五个N-连接糖基化共有位点,具体如下:三个位于N端,两个位于第二个细胞外环(ECL2)表面。为了研究N-连接糖基化在PAR1信号传导和转运调节中的作用,我们构建了共有位点关键天冬酰胺发生突变的突变体。在此,我们报告PAR1的N端和ECL2均为N-连接糖基化位点,但在受体信号传导和转运调节中具有不同功能。PAR1 N端的N-连接糖基化对于转运至细胞表面很重要,而ECL2处缺乏糖基化的PAR1突变体(NA ECL2)像野生型受体一样转运至细胞表面。然而,与野生型受体相比,激活的PAR1 NA ECL2突变体的内化受损,而未激活受体的组成型内化保持完整。值得注意的是,与野生型受体相比,凝血酶激活的PAR1 NA ECL2突变体显示出增强的最大信号反应。PAR1 NA ECL2突变体信号增加并非由于凝血酶切割受体的能力或信号终止机制存在缺陷。相反,PAR1 NA ECL2突变体在凝血酶刺激的G蛋白信号传导中表现出更高的效能。因此,PAR1细胞外表面的N-连接糖基化可能影响配体对接相互作用和活性受体构象的稳定性。总之,这些研究强烈表明,PAR1在N端与ECL2表面的N-连接糖基化具有不同功能,对受体转运的正确调节和凝血酶信号的保真度至关重要。